Suppr超能文献

分子猫过敏原的最新情况:猫源Fel d 1及其他过敏原。第1章:主要猫过敏原Fel d 1

An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen.

作者信息

Bonnet B, Messaoudi K, Jacomet F, Michaud E, Fauquert J L, Caillaud D, Evrard B

机构信息

1Laboratoire d'Immunologie, ECREIN, UMR1019 Unité de Nutrition Humaine, Université Clermont Auvergne, 63000 Clermont-Ferrand, France.

2Service d'Immunologie, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.

出版信息

Allergy Asthma Clin Immunol. 2018 Apr 10;14:14. doi: 10.1186/s13223-018-0239-8. eCollection 2018.

Abstract

BACKGROUND

Cats are the major source of indoor inhalant allergens after house dust mites. The global incidence of cat allergies is rising sharply, posing a major public health problem. Ten cat allergens have been identified. The major allergen responsible for symptoms is Fel d 1, a secretoglobin and not a lipocalin, making the cat a special case among mammals.

MAIN BODY

Given its clinical predominance, it is essential to have a good knowledge of this allergenic fraction, including its basic structure, to understand the new exciting diagnostic and therapeutic applications currently in development. The recent arrival of the component-resolved diagnosis, which uses molecular allergens, represents a unique opportunity to improve our understanding of the disease. Recombinant Fel d 1 is now available for in vitro diagnosis by the anti-Fel d 1 specific IgE assay. The first part of the review will seek to describe the recent advances related to Fel d 1 in terms of positive diagnosis and assessment of disease severity. In daily practice, anti-Fel d 1 IgE tend to replace those directed against the overall extract but is this attitude justified? We will look at the most recent arguments to try to answer this question. In parallel, a second revolution is taking place thanks to molecular engineering, which has allowed the development of various forms of recombinant Fel d 1 and which seeks to modify the immunomodulatory properties of the molecule and thus the clinical history of the disease via various modalities of anti-Fel d 1-specific immunotherapy. We will endeavor to give a clear and practical overview of all these trends.

摘要

背景

猫是继屋尘螨之后室内吸入性过敏原的主要来源。全球猫过敏的发病率正在急剧上升,这构成了一个重大的公共卫生问题。已鉴定出十种猫过敏原。引发症状的主要过敏原是Fel d 1,它是一种分泌球蛋白而非脂质运载蛋白,这使得猫在哺乳动物中成为一个特殊案例。

正文

鉴于其在临床上的主导地位,深入了解这种过敏原成分,包括其基本结构,对于理解目前正在开发的令人兴奋的新诊断和治疗应用至关重要。最近出现的采用分子过敏原的组分分辨诊断,为增进我们对该疾病的理解提供了独特的机会。重组Fel d 1现已可通过抗Fel d 1特异性IgE检测用于体外诊断。综述的第一部分将试图描述在阳性诊断和疾病严重程度评估方面与Fel d 1相关的最新进展。在日常实践中,抗Fel d 1 IgE往往会取代针对整体提取物的IgE,但这种做法是否合理呢?我们将审视最新的论据以试图回答这个问题。与此同时,由于分子工程学的发展正在发生第二次变革,分子工程学已使得开发出各种形式的重组Fel d 1成为可能,并且试图通过各种抗Fel d 1特异性免疫疗法来改变该分子的免疫调节特性,进而改变疾病的临床进程。我们将努力对所有这些趋势给出清晰且实用的概述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验